Clinical Trials Directory

Trials / Completed

CompletedNCT00396136

COSMO Post Approval Registry: Corox OTW Steroid LV Lead Monitoring

Corox OTW Steroid LV Lead Monitoring

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
221 (actual)
Sponsor
Biotronik, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this post approval registry is to confirm the long-term safety and effectiveness of the Corox Over-the-wire (OTW) Steroid Left Ventricular (LV) lead as used in conjunction with a BIOTRONK cardiac resynchronization therapy defibrillator (CRT-D). The Corox OTW Steroid LV Lead is capable of providing permanent pacing therapy to the left ventricle in a CRT-D system. The following are the specific objectives to be evaluated during this post-approval registry: * Long-term effectiveness of the COROX OTW Steroid in providing biventricular pacing * Safety of the COROX OTW Steroid LV pacing lead

Detailed description

This post approval registry enrolled 221 patients from 34 centers. The collection of registry data continued for three years for each enrolled subject. Potential patients were screened by the enrolling physician according to the detailed inclusion and exclusion criteria below. The specific required visits for this registry are: Enrollment, Three-month, Six month, One-year, Routine Follow-Ups (every subsequent 6 months), Interim follow-ups for Corox OTW Steroid LV lead related visits, and Out of Service visit. Data will be collected at each patient follow-up. The programmed pacing parameters, LV pacing impedance, and LV pacing threshold measurement at 0.5ms pulse width will be obtained. The programming parameters will be set to best suit each patient. If adequate system function, including effective CRT, cannot be obtained, the patient should not be selected for the registry.

Conditions

Interventions

TypeNameDescription
DEVICECorox OTW Steroid Left Ventricular LeadThis is a registry: no study required interventions necessary.

Timeline

Start date
2006-10-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2006-11-06
Last updated
2012-05-28
Results posted
2012-05-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00396136. Inclusion in this directory is not an endorsement.